Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite challenges like cost and access.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8534 ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8534 ...

Cell therapy biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of ...

In this episode of Targeted Talks, Alfred L. Garfall, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in ...

The Oregon Stem Cell Center conducts basic and applied research in the field of Stem Cell Biology with the long term goal to harness the properties of stem cells for regenerative medicine and cell ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE ...

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in patients (pts)with 1 st line non-squamous NSCLC.

With Its Science-backed Products And Global Celebrity Following, Augustinus Bader Is Transforming The Skincare Wardrobes Of ...